• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Endo Partners Paladin Pharma to Commercialize Wynzora in Canada

    PR NEWSWIRE

    Enforcement Report - Week of June 7, 2023

    FDA

    Glenmark gets USFDA nod for generic drug with 180-day exclusivity

    ECONOMIC TIMES

    EPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA®

    GLOBENEWSWIRE

    Enforcement Report - Week of July 6, 2022

    FDA

    Glenmark receives ANDA approval for topical treatment of plaque psoriasis

    ET HEALTH

    EPI Health and MC2 Therapeutics Announce Wynzora(R) Cream (calcipotriene)

    YAHOO

    LEO Pharma announces U.S. FDA approval for Enstilar®

    PRESS RELEASE

    PerrigoUk Finco`s Generic Betamethasone Dipropionate Receives Approval In US

    FDA

    Taro`s Generic BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE Receives Approval In US

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Enstilar 207589 (Calcipotriene and Betamethasone Dipropionate) Topical Foam 0.005%/0.064%

    FDA

    MC2 Therapeutics Announces FDA Approval of Wynzora® Cream

    B3CNEWSWIRE

    Lipidor, Cadila to conduct Ph III study of anti-psoriasis candidate

    BIOSPECTRUMASIA

    LEO Pharma Presents Results From Study of Twice-Weekly Enstilar®

    BUSINESSWIRE

    Tolmar`s Generic Betamethasone Dipropionate;Calcipotriene Receives Approval in US

    FDA

    Bicycle Therapeutics to Updated Data from PhI/IIa Trial Evaluating Lead BT1718

    BUSINESSWIRE

    LEO Pharma Announces USFDA Expanded Regulatory Approvals for Enstilar®

    BUSINESSWIRE

    FDA approves SORILUX(R) for Adolescent Plaque Psoriasis

    BIOSPECTRUMASIA

    Enforcement Report - Week of February 28, 2018

    FDA

    FDA approves Lupin’s generic Dovonex Scalp Solution

    DRUG STORE NEWS

    Novel Labs Generic Calcipotriene Receives Approval In US

    FDA

    Enforcement Report - Week of March 15, 2017

    FDA

    Enforcement Report - Week of February 22, 2017

    FDA

    SMC green light for LEO’s Enstilar

    PHARMATIMES

    LEO Pharma Receives Scientific Approval of Enstilar® for the Treatment of Psoriasis in EU

    PR NEWSWIRE

    Glenmark`s Generic Calcipotriene (0.005% Topical) Approved in US For Psoriasis

    FDA

    Glenmark`s Generic Calcipotriene (0.005%) Tentatively Approved in US For Psoriasis

    FDA

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.